Quackbase!

A database that tracks dubious medical claims.

Response number: 77

Responder: ASASA

Date of response: Oct. 7, 2011

Type of response: Ruling

ASASA dismissed Solal's appeal

Claims dealt with in this response

Claim no 58: Solal Technologies Increases risk of heart attack, diabetes, depression and arthritis Omega deficiency made on 2010-10-04 - Untested and implausible

Documents relevant to this claim

ASA Dismisses Solal Appeal

Copyright © 2011 Treatment Action Campaign and Community Media Trust.
The aim of Quackdown is to inform consumers and patients about untested and implausible health-care claims.
Quackdown is implemented using free and open source software.
Unless otherwise noted, all material on the site is published under the Creative Commons Attribution 3.0 Unported license.
The site is implemented using the Django web framework and the django-pubman content management system.
The source for Quackdown can be downloaded from Github.